MedPath

Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues

Not Applicable
Conditions
Breastfeeding
Registration Number
NCT02233439
Lead Sponsor
Università degli Studi dell'Insubria
Brief Summary

The purpose of this study is to assess the effectiveness of a commercially available product containing a combination of Silybum marianum and Galega officinalis to support continuation or augmentation of breast milk production.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
210
Inclusion Criteria
  • singleton, term delivery
  • >2.5 kg newborn weight
  • lactation-deficiency
Exclusion Criteria
  • Neonatal Intensive Care Unit admission
  • use of galactagogue drugs
  • allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Percentage of mothers who exclusively breastfeed their childAt 6 weeks postpartum
Secondary Outcome Measures
NameTimeMethod
Rate of breastfeeding (either exclusively or as a supplement to formula feeding )at 6 weeks and 3 months
Volume (mL) and frequency (times a day) of formula6 weeks postpartum
weight gain experienced by the newborns6 weeks postpartum
serum prolactin levelat baseline and 6 weeks after treatment
Rate of maternal allergic reactions and gastrointestinal side effects6 weeks postpartum

Trial Locations

Locations (1)

Azienda Ospedaliero-Universitaria Ospedale di Circolo e Fondazione Macchi, Presidio F. Del Ponte

🇮🇹

Varese, Italy

Azienda Ospedaliero-Universitaria Ospedale di Circolo e Fondazione Macchi, Presidio F. Del Ponte
🇮🇹Varese, Italy
Antonella Cromi, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.